… COVID-19 were included in this review. Among them, 46(1.8%) MS patients died(the global
death-to-case ratio of Covid-19 … between DMT-use and COVID-19 disease- course was not …

… and safety of COVID-19 vaccination in patients with CNS demyelinating disease, we aimed
to explore COVID-19 infections and adverse events following COVID-19 vaccination among …

… relationship between the COVID-19 vaccine and central nervous system demyelination. …
All case reports of MS and NMOSD patients following the COVID-19 vaccine were included in …

… auto-immune signature of inflammatory demyelinating diseases that might … COVID-19
pandemic implied an accelerated vaccination scheme with a great number of subjects vaccinated …

… (ADEM), developed after being vaccinated using the Oxford/AstraZeneca COVID-19 vaccine.
ADEM is a rare autoimmune disease, causing demyelination in the brain and spinal cord. A …

… It has been shown that receiving the vaccine after recovering from COVID-19, as in our
case, was associated with a higher risk of permanent health problems. Therefore, monitoring of …

… demyelination following COVID-19 vaccination. Extensive workups for the other causes such
as both primary and secondary demyelinating … pre-existing primary demyelinating disorders …

… , with demyelinating features indicating the acute inflammatory demyelinating … losses,
both acute inflammatory demyelinating polyradiculoneuropathy and the acute motor …

… central nervous system demyelinating diseases. The COVID-19 vaccine is being administered
to the entire population, but to date, little association between vaccination and the risk of …

Background and purpose Guillain-Barré-Syndrome (GBS) can follow COVID-19 vaccination,
with clinical and paraclinical features still to be precisely assessed. We describe a cohort of …